Q32 Bio (QTTB) Current Assets (2017 - 2026)

Q32 Bio's Current Assets history runs 10 years deep, the most recent figure standing at $57.2 million for Q1 2026.

• In Q1 2026, Current Assets fell 16.65% year-over-year to $57.2 million; the TTM figure through Mar 2026 stood at $57.2 million (down 16.65% YoY), while the FY2025 annual figure was $55.0 million, down 32.77% from the prior year.
• Current Assets was $57.2 million for Q1 2026 at Q32 Bio, up from $55.0 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $262.4 million in Q1 2022 to a low of $28.7 million in Q4 2023.
• Historically, Current Assets has averaged $119.5 million across 5 years, with a median of $106.6 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Current Assets plunged 84.14% in 2023, then soared 185.13% in 2024.
• A 5-year view of Current Assets shows it stood at $181.0 million in 2022, then slumped by 84.14% to $28.7 million in 2023, then jumped by 185.13% to $81.9 million in 2024, then slumped by 32.77% to $55.0 million in 2025, then gained by 3.91% to $57.2 million in 2026.
• The last three Current Assets figures came in at $57.2 million (Q1 2026), $55.0 million (Q4 2025), and $50.8 million (Q3 2025), per Business Quant data.